Compounds > glycyl-arginyl-glycyl-aspartyl-seryl-proline
Page last updated: 2024-09-03

glycyl-arginyl-glycyl-aspartyl-seryl-proline and cyclic gmp

glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with cyclic gmp in 1 studies

Compound Research Comparison

Studies
(glycyl-arginyl-glycyl-aspartyl-seryl-proline)		Trials
(glycyl-arginyl-glycyl-aspartyl-seryl-proline)		Recent Studies (post-2010)
(glycyl-arginyl-glycyl-aspartyl-seryl-proline)		Studies
(cyclic gmp)		Trials
(cyclic gmp)		Recent Studies (post-2010) (cyclic gmp)
16212022,3463334,062

Protein Interaction Comparison

ProteinTaxonomyglycyl-arginyl-glycyl-aspartyl-seryl-proline (IC50)cyclic gmp (IC50)
Phosphodiesterase Bos taurus (cattle)0.1
cGMP-inhibited 3',5'-cyclic phosphodiesterase BHomo sapiens (human)2.4
cGMP-inhibited 3',5'-cyclic phosphodiesterase AHomo sapiens (human)2.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Golledge, J; Hicks, RC; Mir-Hasseine, R; Powell, JT1

Other Studies

1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and cyclic gmp

ArticleYear
Vasoactive effects of fibrinogen on saphenous vein.
    Nature, 1996, Feb-29, Volume: 379, Issue:6568

    Topics: Animals; Cyclic GMP; Fibrinogen; Humans; In Vitro Techniques; Intercellular Adhesion Molecule-1; Mice; Oligopeptides; Peptide Fragments; Saphenous Vein; Thrombin; Vasodilation

1996